1. Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver. 2015; 9:449–463.
2. Dahiya DS, Nivedita F, Perisetti A, et al. Clinical outcomes and complications for achalasia patients admitted after per-oral endoscopic myotomy. Gastroenterology Res. 2023; 16:141–148.
3. Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014; 383:83–93.
4. Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011; 8:311–319.
5. Gaber CE, Eluri S, Cotton CC, et al. Epidemiologic and economic burden of achalasia in the United States. Clin Gastroenterol Hepatol. 2022; 20:342–352.
6. Gupta K, Khan A, Chalhoub J, et al. Rehospitalization, treatment, and resource use after inpatient admission for achalasia in the USA. Dig Dis Sci. 2021; 66:4149–4158.
7. Haseeb M, Khan Z, Kamal MU, et al. Short-term outcomes after peroral endoscopic myotomy, Heller myotomy, and pneumatic dilation in patients with achalasia: a nationwide analysis. Gastrointest Endosc. 2023; 97:871–879.
8. Li H, Peng W, Huang S, et al. The 2 years' long-term efficacy and safety of peroral endoscopic myotomy for the treatment of achalasia: a systematic review. J Cardiothorac Surg. 2019; 14:1.
9. Ofosu A, Mohan BP, Ichkhanian Y, et al. Peroral endoscopic myotomy (POEM) vs pneumatic dilation (PD) in treatment of achalasia: A meta-analysis of studies with ≥12-month follow-up. Endosc Int Open. 2021; 9:E1097–E1107.